Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.
<h4>Background</h4>Calcimimetic agents lower serum parathyroid hormone levels in people with chronic kidney disease (CKD), but treatment effects on patient-relevant outcomes are uncertain. We conducted a systematic review and meta-analysis to summarize the benefits and harms of calcimime...
Saved in:
Main Authors: | Suetonia C Palmer, Ionut Nistor, Jonathan C Craig, Fabio Pellegrini, Piergiorgio Messa, Marcello Tonelli, Adrian Covic, Giovanni F M Strippoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Medicine |
Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1001436&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CINACALCET IN TREATMENT OF HYPERPARATHYROIDISM IN RECIPIENTS OF RENAL GRAFT
by: O. N. Vetchinnikova, et al.
Published: (2014-05-01) -
Cinacalcet en el tratamiento del hiperparatiroidismo secundario
by: Karen Gabriela Sulca Espín, et al.
Published: (2025-07-01) -
Exploring the role of metabolomics in kidney transplantation: a systematic review of the literature
by: Cezar Valeriu Băluţă, et al.
Published: (2025-06-01) -
PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015-03-01) -
PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)